Bristol-Myers Squibb
BMY
#175
Rank
NZ$226.71 B
Marketcap
NZ$110.91
Share price
1.78%
Change (1 day)
37.85%
Change (1 year)

EPS for Bristol-Myers Squibb (BMY)

EPS in 2026 (TTM): NZ$7.91

According to Bristol-Myers Squibb's latest financial reports the company's current EPS (TTM) is NZ$8.06. In 2025 the company made an earnings per share (EPS) of NZ$6.14 an increase over its 2024 EPS that were of NZ-$7.85.

EPS history for Bristol-Myers Squibb from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$7.9128.76%
2025NZ$6.14-178.28%
2024NZ-$7.85-213.92%
2023NZ$6.8930.2%
2022NZ$5.29-6.04%
2021NZ$5.63-179.29%
2020NZ-$7.10-281.37%
2019NZ$3.92-27.21%
2018NZ$5.38
2016NZ$4.74175.26%
2015NZ$1.72-19.83%
2014NZ$2.15-22.44%
2013NZ$2.7734.48%
2012NZ$2.06

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$15.50 92.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$11.82 46.70%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$1.35-83.26%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$6.34-21.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$53.05 558.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$28.79 257.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$3.38-58.09%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
NZ$10.08 25.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$2.25-72.12%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$11.86 47.14%๐Ÿ‡ฌ๐Ÿ‡ง UK